Failure to achieve a complete hematologic response at the time of a major cytogenetic response with second-generation tyrosine kinase inhibitors is associated with a poor prognosis among patients with chronic myeloid leukemia in accelerated or blast phase
- Carmen Fava
- , Hagop M. Kantarjian
- , Elias Jabbour
- , Susan O'Brien
- , Nitin Jain
- , Mary Beth Rios
- , Guillermo Garcia-Manero
- , Farhad Ravandi
- , Srdan Verstovsek
- , Gautam Borthakur
- , Jianqin Shan
- , Jorge Cortes
Research output: Contribution to journal › Article › peer-review
29
Link opens in a new tab
Scopus
citations